RHHBY

Roche Holding AG [RHHBY] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

RHHBY Stock Summary

Top 10 Correlated ETFs

RHHBY

Top 10 Correlated Stocks

RHHBY

In the News

RHHBY Financial details

Company Rating
-
Market Cap
198.37B
Income
18.96B
Revenue
105.01B
Book val./share
-
Cash/share
-
Dividend
1.29
Dividend %
4.09%
Employees
103.61K
Optionable
No
Shortable
Yes
Earnings
25 Jul 2024
P/E
16.22
Forward P/E
-
PEG
3.08
P/S
3.19
P/B
7.2
P/C
-
P/FCF
14.56
Quick Ratio
0.92
Current Ratio
1.24
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
23.71
EPS next Y
-
EPS next Q
-
EPS this Y
-7.34%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-1.81%
Revenue last 5Y
-0.34%
Revenue Q/Q
-2.83%
EPS Q/Q
-38.75%
-
-
-
-
SMA20
-1.23%
SMA50
3.81%
SMA100
-5.09%
Inst Own
-
Inst Trans
-
ROA
14%
ROE
47%
ROC
0.29%
Gross Margin
68%
Oper. Margin
28%
Profit Margin
20%
Payout
60%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
30.06-40.48
52W High
-2.9%
52W Low
+29.47%
RSI
38.02
Rel Volume
1.03
Avg Volume
2.21M
Volume
2.28M
Perf Week
-5.59%
Perf Month
-1.97%
Perf Quarter
-2.34%
Perf Half Y
-1.04%
-
-
-
-
Beta
0.148
-
-
Volatility
0.91%, 0.66%
Prev Close
-0.18%
Price
38.84
Change
-1.62%

RHHBY Financial Performance

RHHBY Dividend History

RHHBY Frequently Asked Questions

What is Roche Holding AG stock symbol ?

Roche Holding AG is a CH stock and trading under the symbol RHHBY

What is Roche Holding AG stock quote today ?

Roche Holding AG stock price is $38.84 today.

Is Roche Holding AG stock public?

Yes, Roche Holding AG is a publicly traded company.

Something similar

Top by Market Cap
MSFT
VTI
NVDA
LLY.DE
VFINX
Top Correlated ETFs
IXJ
GDOC
VIGI
IGRO
PPH
Top Correlated Stocks
MKKGY
BNTGY
5929.T
BZLFY
SONVY
Similar Market Cap
NSRGY
001080.KS
004250.KS
0GWB.IL
0002.HK

Company Profile

Healthcare Drug Manufacturers - General
  • Volume Average 2.21M
  • Market Capitalization 198.37B
  • Employee 103.61K
  • CEO Dr. Thomas Schinecker
  • Headquarters Basel,CH
  • IPO Date 2003-08-20
  • Website https://www.roche.com

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. The company was founded in 1896 and is headquartered in Basel, Switzerland.